doi: 10.5732/cjc.012.10011
Stereotactic radiosurgery: a “targeted” therapy for cancer
Ming Zeng, Liang-Fu Han
Department of Radiation Oncology, Zangmeister Cancer Center, Columbus, OH 43219, USA
[Abstract] The developments of medicine always follow innovations in science and technology. In the past decade, such innovations have made cancer-related targeted therapies possible. In general, the term "targeted therapy" has been used in reference to cellular and molecular level oriented therapies. However, improvements in the delivery and planning of traditional radiation therapy have also provided cancer patients more options for "targeted" treatment, notably stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). In this review, the progress and controversies of SRS and SBRT are discussed to show the role of stereotactic radiation therapy in the ever evolving multidisciplinary care of cancer patients.
Chinese Journal of Cancer 2012, Volume: 31, Issue 10, Page: 471-475
[ PDF Full-text ]
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]
Cite this article
Ming Zeng, Liang-Fu Han. Stereotactic radiosurgery: a “targeted” therapy for cancer. Chin J Cancer. 2012, 31(10):471-475. doi:10.5732/cjc.012.10011
Export citations
EndNote
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]
Cite this article
Ming Zeng, Liang-Fu Han. Stereotactic radiosurgery: a “targeted” therapy for cancer. Chin J Cancer. 2012, 31(10):471-475. doi:10.5732/cjc.012.10011
Export citations
EndNote
SHARE THIS ARTICLE
Comments: